- Home
- CAKE vs PTGX Comparison
CAKE vs PTGX Comparison
Compare CAKE & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- PTGX
- Stock Information
- Founded
- CAKE 1972
- PTGX 2006
- Country
- CAKE United States
- PTGX United States
- Employees
- CAKE N/A
- PTGX N/A
- Industry
- CAKE Restaurants
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- CAKE Consumer Discretionary
- PTGX Health Care
- Exchange
- CAKE Nasdaq
- PTGX Nasdaq
- Market Cap
- CAKE 2.5B
- PTGX 2.7B
- IPO Year
- CAKE 1992
- PTGX 2016
- Fundamental
- Price
- CAKE $50.39
- PTGX $40.69
- Analyst Decision
- CAKE Hold
- PTGX Strong Buy
- Analyst Count
- CAKE 16
- PTGX 8
- Target Price
- CAKE $47.33
- PTGX $54.63
- AVG Volume (30 Days)
- CAKE 1.0M
- PTGX 817.5K
- Earning Date
- CAKE 10-29-2024
- PTGX 11-07-2024
- Dividend Yield
- CAKE 2.15%
- PTGX N/A
- EPS Growth
- CAKE 52.49
- PTGX N/A
- EPS
- CAKE 2.64
- PTGX 2.68
- Revenue
- CAKE $3,537,745,000.00
- PTGX $323,795,000.00
- Revenue This Year
- CAKE $5.97
- PTGX $441.08
- Revenue Next Year
- CAKE $5.40
- PTGX N/A
- P/E Ratio
- CAKE $19.47
- PTGX $15.16
- Revenue Growth
- CAKE 2.39
- PTGX 125.73
- 52 Week Low
- CAKE $31.24
- PTGX $20.71
- 52 Week High
- CAKE $52.10
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- CAKE 57.81
- PTGX 42.76
- Support Level
- CAKE $49.33
- PTGX $39.60
- Resistance Level
- CAKE $51.80
- PTGX $41.97
- Average True Range (ATR)
- CAKE 1.53
- PTGX 1.80
- MACD
- CAKE -0.13
- PTGX -0.04
- Stochastic Oscillator
- CAKE 55.47
- PTGX 18.17
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.